Article

Vitrectomy beneficial with retained lens fragments

An immediate vitrectomy should be considered in patients with retained intravitreal fragments of the crystalline lens after complicated cataract surgery. Eyes that underwent immediate vitrectomy had better visual acuity and a lower retinal detachment rate than eyes that underwent delayed vitrectomy.

Chicago-An immediate vitrectomy should be considered in patients with retained intravitreal fragments of the crystalline lens after complicated cataract surgery. Eyes that underwent immediate vitrectomy had better visual acuity (VA) than eyes that underwent delayed vitrectomy, according to Michael W. Stewart, MD, who reported his results at the American Society of Cataract and Refractive Surgery annual meeting.

"The first reports on retained crystalline lens fragments emerged in the literature in the early 1990s and found that from 50% to 67% of patients achieved subsequent visual acuities of 20/40 or better," said Dr. Stewart, who is affiliated with the Department of Ophthalmology, Mayo Clinic, Jacksonville, FL. "Later reports, early in the next decade, showed comparable visual acuity results, but these studies also emphasized the importance of the development of retinal detachments and glaucoma as adverse visual outcomes.

"Some authors proposed that immediate vitrectomy performed in these patients results in improved visual acuity. However, other large studies contradicted that thesis," Dr. Stewart said. "Other authors thought that immediate vitrectomy minimized the risk of the development of secondary glaucoma."

He summarized the experience with patients with retained lens fragments at the Mayo Clinic. An 8-year retrospective analysis of 6,676 cataract surgeries performed at the Mayo Clinic indicated that 0.48% of cases had retained crystalline lens fragments, Dr. Stewart said.

Read the full story in the August 1 issue of Ophthalmology Times.

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
(Image credit: Ophthalmology Times) Inside NYEE’s new refractive solutions center with Kira Manusis, MD
(Image credit: Ophthalmology Times) Dilsher Dhoot, MD, on the evolution of geographic atrophy therapy: where are we now?
(Image credit: Ophthalmology Times Europe) Anat Loewenstein, MD, shares insights on the real-world results of remote retinal imaging
(Image credit: Ophthalmology Times) Two-wavelength autofluorescence for macular xanthophyll carotenoids with Christine Curcio, PhD
(Image credit: Ophthalmology Times) FLIO and the brain: Making the invisible visible with Robert Sergott, MD
(Image credit: Ophthalmology Times) Structure-function correlates using high-res OCT images with Karl Csaky, MD, PhD
(Image credit: Ophthalmology Times) SriniVas Sadda, MD, on high-res OCT of atrophic and precursor lesions in AMD
(Image credit: Ophthalmology Times) Christine Curcio, PhD, shares histology update supporting review software and revised nomenclature for <3 μm OCT
1 expert is featured in this series.
© 2025 MJH Life Sciences

All rights reserved.